Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natalia Neparidze

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatmentsNatalia Neparidze, Jill Lacy
Clinical Case Reports|May 11, 2018
Hyperbilirubinemia following lenalidomide administrationVeronica Azmy, Natalia Neparidze
Clinical Advances in Hematology & Oncology : H&O|December 31, 2009
Waldenstrom's macroglobulinemia: Recent advances in biology and therapyNatalia Neparidze, Madhav V Dhodapkar
Annals of the New York Academy of Sciences|September 23, 2009
Harnessing CD1d-restricted T cells toward antitumor immunity in humansNatalia Neparidze, Madhav V Dhodapkar
Clinical Case Reports|March 28, 2022
Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case reportLake R Crawford, Natalia Neparidze
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation StudyIshfaq Ahmad, Rong Wang, Natalia Neparidze, et al.
Research and Practice in Thrombosis and Haemostasis|June 22, 2026
Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleedingTarun Tyagi, Kanika Jain, Martin Matthews, et al.
JCO Oncology Practice|May 4, 2026
Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple MyelomaRong Wang, Mengmeng Ji, Natalia Neparidze, et al.
Cancers|June 26, 2026
Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma Across a Regional Academic-Community NetworkPoy Theprungsirikul, Amer Al-Musa, Noffar Bar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple MyelomaKishan K Patel, Smith Giri, Terri L Parker, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Clinical Advances in Hematology & Oncology : H&O|July 9, 2014
Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatmentsNatalia Neparidze, Jill Lacy
Clinical Case Reports|May 11, 2018
Hyperbilirubinemia following lenalidomide administrationVeronica Azmy, Natalia Neparidze
Clinical Advances in Hematology & Oncology : H&O|December 31, 2009
Waldenstrom's macroglobulinemia: Recent advances in biology and therapyNatalia Neparidze, Madhav V Dhodapkar
Annals of the New York Academy of Sciences|September 23, 2009
Harnessing CD1d-restricted T cells toward antitumor immunity in humansNatalia Neparidze, Madhav V Dhodapkar
Clinical Case Reports|March 28, 2022
Refractory autoimmune hemolytic anemia in a systemic lupus erythematosus patient: A clinical case reportLake R Crawford, Natalia Neparidze
Clinical Lymphoma, Myeloma & Leukemia|July 2, 2026
Potential Benefits and Harms of Screening Strategies for Monoclonal Gammopathy of Undetermined Significance in the US: A Simulation StudyIshfaq Ahmad, Rong Wang, Natalia Neparidze, et al.
Research and Practice in Thrombosis and Haemostasis|June 22, 2026
Real-world investigation of platelet apoptosis for mechanistic insights into severe immune thrombocytopenia and bleedingTarun Tyagi, Kanika Jain, Martin Matthews, et al.
JCO Oncology Practice|May 4, 2026
Immunomodulatory Agent Adherence Trajectories and Survival Among Older Patients With Multiple MyelomaRong Wang, Mengmeng Ji, Natalia Neparidze, et al.
Cancers|June 26, 2026
Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma Across a Regional Academic-Community NetworkPoy Theprungsirikul, Amer Al-Musa, Noffar Bar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2021
Cost-Effectiveness of First-Line Versus Second-Line Use of Daratumumab in Older, Transplant-Ineligible Patients With Multiple MyelomaKishan K Patel, Smith Giri, Terri L Parker, et al.
Pageof 5